2020
DOI: 10.1001/jamanetworkopen.2020.11044
|View full text |Cite
|
Sign up to set email alerts
|

Association of Gender and Race With Allocation of Advanced Heart Failure Therapies

Abstract: IMPORTANCE Racial bias is associated with the allocation of advanced heart failure therapies, heart transplants, and ventricular assist devices. It is unknown whether gender and racial biases are associated with the allocation of advanced therapies among women. OBJECTIVE To determine whether the intersection of patient gender and race is associated with the decision-making of clinicians during the allocation of advanced heart failure therapies. DESIGN, SETTING, AND PARTICIPANTS In this qualitative study, 46 US… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
104
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 102 publications
(107 citation statements)
references
References 39 publications
3
104
0
Order By: Relevance
“…Once women have CVD, there are continued sex disparities in their diagnosis, treatment, and management, resulting in worse outcomes for women. Such sex differences have been demonstrated across CVD diagnoses including acute coronary syndromes, heart failure, and valvular disease with delays in care, [13] underutilization of guideline directed medical therapies and cardiac rehabilitation, [2] and less aggressive treatment, [14] , [15] , [16] when compared with men. As a result, we continue to see higher mortality rates and rehospitalizations in women, compared with men.…”
Section: The Problemmentioning
confidence: 99%
“…Once women have CVD, there are continued sex disparities in their diagnosis, treatment, and management, resulting in worse outcomes for women. Such sex differences have been demonstrated across CVD diagnoses including acute coronary syndromes, heart failure, and valvular disease with delays in care, [13] underutilization of guideline directed medical therapies and cardiac rehabilitation, [2] and less aggressive treatment, [14] , [15] , [16] when compared with men. As a result, we continue to see higher mortality rates and rehospitalizations in women, compared with men.…”
Section: The Problemmentioning
confidence: 99%
“…23 Two studies by Breathett and colleagues used clinical vignettes to test for physician bias in allocation of advanced heart failure therapies, concluding that racial bias may delay initiation of such therapies in the clinical setting, and may bias decision-making towards recommending destination LVAD therapy, rather than transplant wait listing, for Black patients. 24,25 Although differences in timing of LVAD implantation are concerning for the potential negative impact on outcomes of Black as compared to White heart transplant candidates, we acknowledge that prior evidence demonstrating poorer outcomes with delayed LVAD implantation is limited. For example, Kitada et al described no differences in wait list mortality in an unadjusted analysis of pre- vs. post-listing LVAD implantation, while Brown et al described no impact of absolute duration of LVAD therapy on post-transplant outcomes among patients whose LVAD was implanted for >30 days.…”
Section: Discussionmentioning
confidence: 97%
“…performed a national survey of HF clinicians, where clinicians were presented with a clinical vignette describing a patient with advanced HF in need of advanced therapies. All aspects of the clinical presentation including details on medical comorbidities, hemodynamics, adherence with medical therapy, social support, and socioeconomic status were identical, except for the race or gender of the patient being evaluated 20,21 . Discussions with clinicians revealed that women, particularly Black women, were perceived to have more barriers to eligibility for advanced HF therapies, including the assumed burden of childcare and lack of social support.…”
Section: Discussionmentioning
confidence: 99%
“…and lifestyle. Total scores can be categorized as excellent candidate (0-6), good candidate (7)(8)(9)(10)(11)(12)(13)(14)(15)(16)(17)(18)(19)(20), minimally acceptable candidate (21-39), and high-risk candidate (≥40). Patients who were not evaluated using the SIPAT scoring system (N = 282) were rigorously evaluated by our experienced mental health and social work team for their psychiatric history and stability, as well as their substance use history according to standard criteria.…”
Section: Psychosocial Covariatesmentioning
confidence: 99%